Cytodyn Inc (CYDY)

[Scooter McCabe]

So basically completely ignore the science, the safety data, the fact Remdsivir publicly shifted goal posts and went from lives saved to "can we get you out of the hospital 3 days early."

Remedsivir is a very low bar to get over as it doesn't do much at all. It's running the same route it did with Ebola. It essentially a "something is better than nothing" play against a dangerous virus.

So forecasting actually isn't unreasonable for 3 reasons:

1. Vaccine data has not been promising, most are unsure if it will even give the indefinite immunity people are looking for.

2. If fall resurgence is bad we're going to need it.

3. If we get lucky and COVID lies low for the season countries will still stock up to be prepped in the event of another outbreak. No one wants to or can afford to go through another lockdown. This drug gives them the ability to avoid that.